Implications of using hemoglobin A1C for diagnosing diabetes mellitus.
about
Biomarkers in diabetes: hemoglobin A1c, vascular and tissue markersThe Uptake of Screening for Type 2 Diabetes and Prediabetes by Means of Glycated Hemoglobin versus the Oral Glucose Tolerance Test among 18 to 60-Year-Old People of South Asian Origin: A Comparative Study.A Self-assessment Tool for Screening Young Adults at Risk of Type 2 Diabetes Using Strong Heart Family Study DataPREVIEW: Prevention of Diabetes through Lifestyle Intervention and Population Studies in Europe and around the World. Design, Methods, and Baseline Participant Description of an Adult Cohort Enrolled into a Three-Year Randomised Clinical Trial.A two-step screening, measurement of HbA1c in association with FPG, may be useful in predicting diabetes.Diabetes and pre-diabetes as determined by glycated haemoglobin A1c and glucose levels in a developing southern Chinese population.Diabetes mellitus: The epidemic of the century.Trends in diabetes incidence among 7 million insured adults, 2006-2011: the SUPREME-DM projectEvaluation of glycated hemoglobin (HbA1c) for diagnosing type 2 diabetes and prediabetes among Palestinian Arab population.Treatment-dependent and treatment-independent risk factors associated with the risk of diabetes-related events: a retrospective analysis based on 229,042 patients with type 2 diabetes mellitus.Selection of aptamers specific for glycated hemoglobin and total hemoglobin using on-chip SELEX.Prevalence and Cardiovascular Associations of Diabetic Retinopathy and Maculopathy: Results from the Gutenberg Health Study.Analysis and Quantitation of Glycated Hemoglobin by Matrix Assisted Laser Desorption/Ionization Time of Flight Mass Spectrometry.The Accuracy of Diagnostic Methods for Diabetic Retinopathy: A Systematic Review and Meta-AnalysisRational diagnoses of diabetes: the comparison of 1,5-anhydroglucitol with other glycemic markersHbA(1c) diagnostic categories and β-cell function relative to insulin sensitivity in overweight/obese adolescents.Hemoglobin a1c may be an inadequate diagnostic tool for diabetes mellitus in anemic subjects.Optimal Glycemic and Hemoglobin A1c Thresholds for Diagnosing Diabetes Based on Prevalence of Retinopathy in an Iranian Population.HbA1c for diagnosis of type 2 diabetes. Is there an optimal cut point to assess high risk of diabetes complications, and how well does the 6.5% cutoff perform?Use of glycosylated haemoglobin as diagnostic tool in Greenland: prevalence of diagnosed diabetes mellitus.Relationship Between HbA1c and Complex Regional Pain Syndrome in Stroke Patients With Type 2 Diabetes Mellitus.PERFORMANCE OF A1C VERSUS OGTT FOR THE DIAGNOSIS OF PREDIABETES IN A COMMUNITY-BASED SCREENING.Glucose control in diabetes: which target level to aim for?HbA1c for screening and diagnosis of diabetes mellitus.Controversies in prediabetes: do we have a diagnosis?The metabolic deterioration that antedates diabetes: personal trajectories of HbA(1c) and fasting glucose as early indicators and possible triggers for intervention.Use of high-normal levels of haemoglobin A(1C) and fasting plasma glucose for diabetes screening and for prediction: a meta-analysis.Glycated hemoglobin A1C and vitamin D and their association with diabetic retinopathy severity.Glucose: archetypal biomarker in diabetes diagnosis, clinical management and research.Pre-diabetes in adults 45 years and over in Ireland: the Survey of Lifestyle, Attitudes and Nutrition in Ireland 2007.Prevalence and epidemiology of tinea pedis and toenail onychomycosis and antifungal susceptibility of the causative agents in patients with type 2 diabetes in Turkey.Novel biomarkers for prediabetes, diabetes, and associated complications.Tools for practice: screening and diagnosis of type 2 diabetes with HbA1c.An emerging diabetes mellitus diagnosis modality: HbA(1c).Targeted provision of oral iron: the evolution of a practical screening option.Predicting type 2 diabetes mellitus using haemoglobin A1c: a community-based historic cohort study.Optimal HbA1c cutoff for detecting diabetic retinopathy.A novel model enhances HbA1c-based diabetes screening using simple anthropometric, anamnestic, and demographic information.Screening for dysglycaemia in patients with coronary artery disease as reflected by fasting glucose, oral glucose tolerance test, and HbA1c: a report from EUROASPIRE IV--a survey from the European Society of Cardiology.The utility of HbA1c combined with haematocrit for early screening of gestational diabetes mellitus.
P2860
Q26996480-B460CD35-648A-4B9C-9CA4-F9D4BA1A847EQ29353651-A19A20FA-790D-4F76-9F3F-E02A416E0716Q31118956-5EA21B25-3EA1-4A87-B890-1403B8FF17EFQ33852200-DC5AC2B3-5D88-40AE-BC83-785BEE4BEACEQ34257430-EC9B6403-CE02-4D7A-A08B-B16CD11A0580Q34277912-3F4FC4D4-E090-4A6A-8280-6938E682714CQ34671155-953D257E-9E8B-4151-846C-95EA135015E6Q34882597-1779FB0F-EF1A-4818-B5B3-236308D05BB6Q35088520-E0158C7C-80F9-4D4E-8D92-E5AC867EB871Q35128612-660E687D-5020-4DA4-A9E6-0E4F6BF2DF81Q35434962-EC571D5B-7983-4127-90A5-75D301B3321EQ35663730-DBDA4E53-FBB2-4F1C-947D-6E7E96176487Q35886251-46FA8023-D57A-4291-B829-7E36ADD90D69Q36001658-E1699A14-48CA-4324-B17C-1251B0053D73Q36234192-027BA2D5-9524-4517-B8C8-9DCC373272CAQ36426853-B2512FDE-9B1B-41CD-ACC4-B1731887105CQ37275522-3FB74A91-BB84-4242-ABF9-BED1ACFE48E6Q37342171-C82A9566-7E0E-48B2-A359-2EF6213F4DE4Q37359624-39A05225-7373-460C-A3B8-15D91734325EQ37365485-D465F2BF-0EBF-4635-8AC4-007878115A83Q37413265-EC1A7370-9F92-4967-9162-8D169F507265Q37613221-B061BB9D-3B75-49AB-8B88-0E1A26BD05E2Q37982850-A7831A48-E165-4578-A8AB-98CA0F6AF334Q38036145-4D3BC9F1-B75D-4AA6-A98D-1CBD3AD03ADEQ38036774-C5D00D5A-4A4D-44FC-974C-2D1156F6C67DQ38061853-9CFC1109-0436-40A9-9C6C-9BA9A4326BB9Q38130468-AF7C6D64-8F5A-4140-9F6C-BFCE99467676Q38730387-DD1A6423-EBA0-472E-8D50-F62498FE650CQ39296810-08D05CE8-5CA3-4643-8392-97B6B13FC1FDQ39421879-E0F8BB93-9884-4F8E-90CB-E8092CE0962AQ40528000-E21B8A43-945F-4FA0-B119-A3E758090CC8Q41475816-0E4D8258-94AC-4B17-8234-E78A3EAA58F6Q42127410-5D68B14A-6DA7-4CCD-B108-25141C55EA5CQ42594091-54CD9DB4-EDF3-42D1-9F80-959B25A89F14Q43168338-C8DC15BD-8C5B-4A81-9B7E-8737BD910BD4Q43491642-B477FA51-C083-4FAD-9547-62AA9C120A72Q43891913-253EB86E-5CDF-4E9B-BAFA-C4ECCDA8CE04Q44784489-5E545CEB-ACB1-48C8-8D31-7DA4D445FD23Q49159819-C6362D7C-5E39-4037-8462-10B8DD493DF6Q51245280-CDEE6BD1-1933-4E61-9E59-565152D155C6
P2860
Implications of using hemoglobin A1C for diagnosing diabetes mellitus.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Implications of using hemoglobin A1C for diagnosing diabetes mellitus.
@ast
Implications of using hemoglobin A1C for diagnosing diabetes mellitus.
@en
Implications of using hemoglobin A1C for diagnosing diabetes mellitus.
@nl
type
label
Implications of using hemoglobin A1C for diagnosing diabetes mellitus.
@ast
Implications of using hemoglobin A1C for diagnosing diabetes mellitus.
@en
Implications of using hemoglobin A1C for diagnosing diabetes mellitus.
@nl
prefLabel
Implications of using hemoglobin A1C for diagnosing diabetes mellitus.
@ast
Implications of using hemoglobin A1C for diagnosing diabetes mellitus.
@en
Implications of using hemoglobin A1C for diagnosing diabetes mellitus.
@nl
P2860
P1476
Implications of using hemoglobin A1C for diagnosing diabetes mellitus.
@en
P2093
John P Mordes
Samir Malkani
P2860
P304
P356
10.1016/J.AMJMED.2010.11.025
P407
P577
2011-05-01T00:00:00Z